5-HT4 antagonism in irritable bowel syndrome (IBS):: Effect of SB-207266-A on rectal sensitivity and small bowel transit.

被引：0
|
作者：
Houghton, LA
Jackson, NA
Whorwell, PJ
Cooper, S
机构：
[1] SmithKline Beecham Pharmaceut, Harlow CM19 5AW, Essex, England
[2] Univ S Manchester Hosp, Dept Med, Manchester M20 2LR, Lancs, England
来源：
GASTROENTEROLOGY | 1998年 / 114卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(98)83139-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
G3164
引用
收藏
页码：A768 / A768
页数：1
相关论文
共 50 条
  • [1] 5-HT4 receptor antagonism in irritable bowel syndrome:: effect of SB-207266-A on rectal sensitivity and small bowel transit
    Houghton, LA
    Jackson, NA
    Whorwell, PJ
    Cooper, SM
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (11) : 1437 - 1444
  • [2] 5HT(4) antagonism in irritable bowel syndrome (IBS): Effect of SB-207266-A on rectal sensitivity and small bowel transit
    Houghton, LA
    Jackson, NA
    Whorwell, PJ
    Cooper, S
    GUT, 1997, 41 : A26 - A26
  • [3] Piboserod hydrochloride -: SB-207266A -: Treatment of IBS -: 5-HT4 antagonist
    不详
    DRUGS OF THE FUTURE, 2000, 25 (12) : 1323 - 1323
  • [4] Tegaserod, a 5-HT4 receptor partial agonist, relieves key symptoms of irritable bowel syndrome (IBS).
    Mueller-Lissner, S
    Fumagalli, I
    Bardhan, KD
    Pace, F
    Nault, B
    Pecher, EC
    Rueegg, PC
    Lefkowitz, MP
    GASTROENTEROLOGY, 2000, 118 (04) : A175 - A175
  • [5] A pharmacodynamic model of 5-HT4 receptor activation in man: Antagonism by the 5-HT4 receptor antagonist SB-207266
    Cooper, SM
    Haydock, SF
    Tompson, DJ
    Higgins, RG
    Fitzpatrick, KL
    GASTROENTEROLOGY, 1999, 116 (04) : A598 - A598
  • [6] Rectal sensitivity and gastrointestinal symptom severity in irritable bowel syndrome (IBS): Is there a link?
    Syrous, A
    Lindstrom, L
    Lindh, A
    Bjornsson, E
    Abrahamsson, H
    Simren, M
    GASTROENTEROLOGY, 2005, 128 (04) : A110 - A110
  • [7] Nutrient-dependent enhancement of rectal sensitivity in irritable bowel syndrome (IBS)
    Simren, M.
    Agerforz, P.
    Bjornsson, E. S.
    Abrahamsson, H.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2007, 19 (01): : 20 - 29
  • [8] Safety profile of tegaserod, a 5-HT4 receptor agonist, for the treatment of irritable bowel syndrome
    Hasler, WL
    Schoenfeld, P
    DRUG SAFETY, 2004, 27 (09) : 619 - 631
  • [9] Safety Profile of Tegaserod, a 5-HT4 Receptor Agonist, for the Treatment of Irritable Bowel Syndrome
    William L. Hasler
    Philip Schoenfeld
    Drug Safety, 2004, 27 : 619 - 631
  • [10] Tegaserod -: A 5-HT4 agonist for women with constipation-predominant irritable bowel syndrome
    Zimmermann, AE
    FORMULARY, 2002, 37 (09) : 449 - +
12345